Test kit, cutaneous LE
Open Solicitation Posted
- Solicitation number
- SPE2DS27T1845
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- More information
Notice details come from DLA DIBBS. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical office (SPE2DS) seeks quotations for two kits of Test Kit, Cutaneous Leishmaniasis (NSN 6550-01-633-9195), with quotes due November 18, 2026, submitted through DIBBS. The request for quotation carries no set-aside and uses the Fast Auto Evaluation solicitation type.
Delivery is required within 20 days to Fort Bliss, Texas, FOB Destination, with inspection and acceptance at destination. Each kit contains materials for 25 tests. The government file describes an FDA-cleared, hand-held, qualitative, in vitro immunochromatographic assay for rapid detection of Leishmania species antigen in ulcerative skin lesions, with room-temperature storage and an 18-month shelf life that is non-extendable. The file identifies the item as INBIOS International Inc part number CL025 (CAGE 3KJL6). Packaging must comply with DLA Packaging Requirements (RP001), and materials must carry Medical Marking Standard No. 1.
Compliance requirements include DFARS 252.225-7001 (Buy American and Balance of Payments Program), domestic material restrictions under the Berry Amendment (threshold $150,000), destination inspection under FAR 52.246-2, and representations and certifications on covered telecommunications equipment and domestic material sourcing. The contract incorporates the DLA Master Solicitation for Automated Simplified Acquisitions, Revision 106 (November 3, 2026), and the DLA Technical and Quality Master List.
Procurement history shows recent unit costs ranging from approximately $421.73 to $495.00. The procurement is classified under PSC 6550, In Vitro Diagnostic Substances, Reagents, Test Kits And Sets, and NAICS 456199.
Notice text
DLA request for quotation SPE2DS27T1845, issued by DLA office SPE2DS through DIBBS. Quotes are due by 11/18/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, TEST KIT,CUTANEOUS LE, NSN 6550-01-633-9195, 2 KT, delivery in 20 days, PR 7019116556. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DS27T1845.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Test kit, coronavirus | Medical Supply Chain | No set-aside | |
| Antibodies elution KI | Medical Supply Chain | No set-aside | |
| Test kit, fuel microbi | Medical Supply Chain | No set-aside | |
| Test kit, coronavirus and 1 more item | Medical Supply Chain | No set-aside | |
| Brush kit, cytology | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity